In 2026 AI is making personalised CBD practical: the Kanabo × Pomicell partnership and wider industry adoption are enabling evidence‑led, bespoke oils and edibles. This trend promises better‑matched products and smarter recommendations — provided brands pair AI with clear labelling, privacy safeguards and strict advertising compliance.

In 2026 CBD‑adjacent adaptogen and nootropic drinks are leaping from DTC and specialist shops into mainstream UK supermarkets. Major rollouts by Neutonic, Trip and Happy Panda — backed by strong funding, rising awareness and rapid sell‑outs — signal large‑scale retail adoption and an accelerating market projected to grow at a double‑digit CAGR into the early 2030s.

In 2026, UK CBD brands must reassess bottle materials as DRS and EPR reshape packaging economics. This comparison weighs glass, PET and aluminium for potency protection, contamination risk and real‑world sustainability so you can choose the best fit for your needs.